Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Unipolar Major Depression 1Radiation Injuries 1Head and Neck Neoplasms 1Glioblastoma 1Depression 1

Interventions

Radiotherapy 29Cisplatin 12Amifostine 11Radiotherapy, Intensity-Modulated 7Paclitaxel 7Carboplatin 7Etoposide 5Radiosurgery 4Donepezil 4Brachytherapy 4Bevacizumab 4sargramostim 3Surgical Procedures, Operative 3Mental Status and Dementia Tests 3Filgrastim 3Diet Therapy 3Blood Specimen Collection 3Radiation Dose Hypofractionation 2Radiation 2Proton Therapy 2Magnetic Resonance Spectroscopy 2Low-Level Light Therapy 2Lithium 2Hyperbaric Oxygenation 2Heavy Ion Radiotherapy 2Fluorouracil 2Fibroblast Growth Factor 7 2Dexamethasone 2Chemotherapy, Adjuvant 2Androgen Antagonists 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Radiation Injuries × Vortioxetine × Clear all
NCT04818099 2021-03-26

Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 3 Unknown
208 enrolled
Head & Neck

Depression, Head and Neck Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡